Target Name: MTMR1
NCBI ID: G8776
Review Report on MTMR1 Target / Biomarker Content of Review Report on MTMR1 Target / Biomarker
MTMR1
Other Name(s): myotubularin related protein 1 | Phosphatidylinositol-3,5-bisphosphate 3-phosphatase | Myotubularin related protein 1, transcript variant 2 | phosphatidylinositol-3-phosphate phosphatase | MTMR1_HUMAN | Phosphatidylinositol-3-phosphate phosphatase | Myotubularin-related protein 1 | phosphatidylinositol-3,5-bisphosphate 3-phosphatase | MTMR1 variant 2 | Myotubularin-related protein 1 (isoform 2)

Unlocking The Potential of MTMR1: A Protein Target for Muscle and Inflammatory Diseases

MTMR1 (Myotubularin Related Protein 1) is a protein that is expressed in muscle tissue, including skeletal muscles and heart muscles. It is a member of the actinin family, which is a group of proteins that play a critical role in cell signaling and cytoskeletal organization.

MTMR1 is characterized by its unique structure and localization in muscle tissue. It consists of a single polypeptide chain that is composed of 154 amino acids. The protein is expressed in muscle tissue at different levels, and its level of expression is regulated by several factors, including muscle growth, exercise, and disease.

One of the unique features of MTMR1 is its ability to interact with several different proteins, including actinin-3 (Act3), which is a protein that is also known as myosin regulatory protein (MyRP). The interaction between MTMR1 and Act3 is critical for the regulation of muscle contractions.

MTMR1 has also been shown to interact with the protein tyrosine kinase (TK) signaling pathway, which is involved in the regulation of many cellular processes, including muscle growth and maintenance. This interaction between MTMR1 and TK suggests that MTMR1 may be a drug target or biomarker for several diseases, including muscle-related diseases such as myopathies and myopathic neuromuscular disorders.

In addition to its role in muscle signaling, MTMR1 has also been shown to play a critical role in the regulation of inflammation and cellular stress. It has been shown to interact with several different cytokines, including the cytokine interferon-gamma (IFN-纬) . This interaction suggests that MTMR1 may be involved in the regulation of cellular immune responses and may be a potential therapeutic target for several inflammatory diseases.

MTMR1 has also been shown to interact with the protein heat shock protein (Hsp) which is involved in the regulation of protein folding and localization in the cell. This interaction suggests that MTMR1 may be involved in the regulation of protein stability and localization in the cell , which could have implications for the regulation of cellular processes such as protein misfolding and localization.

In conclusion, MTMR1 is a protein that has been identified as a potential drug target or biomarker for several diseases, including muscle-related diseases and inflammatory diseases. Its unique structure and localization in muscle tissue, as well as its interaction with several different proteins, makes it an attractive target for further study and may provide new insights into the regulation of muscle growth, maintenance, and inflammation.

Protein Name: Myotubularin Related Protein 1

Functions: Lipid phosphatase that has high specificity for phosphatidylinositol 3-phosphate and has no activity with phosphatidylinositol 4-phosphate, phosphatidylinositol (4,5)-bisphosphate and phosphatidylinositol (3,4,5)-trisphosphate (PubMed:11733541, PubMed:27018598). Activity with phosphatidylinositol (3,5)-bisphosphate is controversial; it has been shown by PubMed:27018598, while PubMed:11733541 find no activity with this substrate

The "MTMR1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MTMR1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

MTMR10 | MTMR11 | MTMR12 | MTMR14 | MTMR2 | MTMR3 | MTMR4 | MTMR6 | MTMR7 | MTMR8 | MTMR9 | MTMR9LP | MTND1P11 | MTND1P23 | MTND1P3 | MTND1P33 | MTND2P21 | MTND2P28 | MTND4P10 | MTND4P12 | MTND4P17 | MTND4P22 | MTND4P24 | MTND4P28 | MTND4P29 | MTND5P10 | MTND5P16 | MTND5P19 | MTND5P20 | MTND5P31 | MTND5P8 | MTND6P14 | MTND6P4 | MTNR1A | MTNR1B | MTO1 | MTOR | mTOR complex 1 | mTOR complex 2 | MTPAP | MTPN | MTR | MTRES1 | MTREX | MTRF1 | MTRF1L | MTRF1LP2 | MTRFR | MTRNR2L1 | MTRNR2L10 | MTRNR2L11 | MTRNR2L12 | MTRNR2L13 | MTRNR2L2 | MTRNR2L3 | MTRNR2L4 | MTRNR2L5 | MTRNR2L6 | MTRNR2L7 | MTRNR2L8 | MTRNR2L9 | MTRR | MTSS1 | MTSS2 | MTTP | MTURN | MTUS1 | MTUS1-DT | MTUS2 | MTUS2-AS1 | MTVR2 | MTX1 | MTX2 | MTX3 | mu-Calpain (calpain 1) | MUC1 | MUC12 | MUC13 | MUC15 | MUC16 | MUC17 | MUC19 | MUC2 | MUC20 | MUC20P1 | MUC21 | MUC22 | MUC3A | MUC3B | MUC4 | MUC5AC | MUC5B | MUC6 | MUC7 | MUC8 | Mucin | MUCL1 | MUCL3 | MUL1 | Multisubunit histone acetyltransferase complex